CN102688426A - 治疗急性上消化道出血的中药组合物、其制备方法及应用 - Google Patents
治疗急性上消化道出血的中药组合物、其制备方法及应用 Download PDFInfo
- Publication number
- CN102688426A CN102688426A CN2012102092437A CN201210209243A CN102688426A CN 102688426 A CN102688426 A CN 102688426A CN 2012102092437 A CN2012102092437 A CN 2012102092437A CN 201210209243 A CN201210209243 A CN 201210209243A CN 102688426 A CN102688426 A CN 102688426A
- Authority
- CN
- China
- Prior art keywords
- radix
- weight portions
- chinese medicine
- medicine composition
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 89
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title claims description 13
- 230000001154 acute effect Effects 0.000 title abstract description 5
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 title abstract description 3
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 19
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 258
- 238000010828 elution Methods 0.000 claims description 71
- 239000000843 powder Substances 0.000 claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 208000032843 Hemorrhage Diseases 0.000 claims description 48
- 239000000284 extract Substances 0.000 claims description 33
- 239000000243 solution Substances 0.000 claims description 26
- 239000011812 mixed powder Substances 0.000 claims description 23
- 238000002347 injection Methods 0.000 claims description 22
- 239000007924 injection Substances 0.000 claims description 22
- 239000009636 Huang Qi Substances 0.000 claims description 20
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 20
- 241000180649 Panax notoginseng Species 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 19
- 238000005325 percolation Methods 0.000 claims description 19
- 241000218628 Ginkgo Species 0.000 claims description 18
- 210000002438 upper gastrointestinal tract Anatomy 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 16
- 239000002552 dosage form Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 15
- 238000010992 reflux Methods 0.000 claims description 14
- 239000011347 resin Substances 0.000 claims description 14
- 229920005989 resin Polymers 0.000 claims description 14
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 13
- 241001164374 Calyx Species 0.000 claims description 13
- 241000218176 Corydalis Species 0.000 claims description 13
- 235000008597 Diospyros kaki Nutrition 0.000 claims description 13
- 244000236655 Diospyros kaki Species 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 13
- 241000244155 Taenia Species 0.000 claims description 13
- 229940085605 saccharin sodium Drugs 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 230000002421 anti-septic effect Effects 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 230000000274 adsorptive effect Effects 0.000 claims description 7
- 239000003610 charcoal Substances 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 239000004952 Polyamide Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000007900 aqueous suspension Substances 0.000 claims description 5
- 230000008021 deposition Effects 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 229920002647 polyamide Polymers 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000008215 water for injection Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 39
- 238000011282 treatment Methods 0.000 abstract description 19
- 230000023597 hemostasis Effects 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000130781 Arnebia Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 240000003690 Callicarpa japonica Species 0.000 abstract 1
- 235000017595 Callicarpa japonica Nutrition 0.000 abstract 1
- 244000060020 Chamaerops excelsa Species 0.000 abstract 1
- 235000013164 Chamaerops excelsa Nutrition 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 241000729173 Cirsium japonicum Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 76
- 239000008280 blood Substances 0.000 description 76
- 210000002784 stomach Anatomy 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 25
- 210000000952 spleen Anatomy 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 18
- 208000034507 Haematemesis Diseases 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 17
- 208000034158 bleeding Diseases 0.000 description 15
- 230000000740 bleeding effect Effects 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 14
- 208000025865 Ulcer Diseases 0.000 description 12
- 231100000397 ulcer Toxicity 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 208000035861 hematochezia Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 230000002550 fecal effect Effects 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 210000001809 melena Anatomy 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000002183 duodenal effect Effects 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 208000006750 hematuria Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 206010013781 dry mouth Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000000025 haemostatic effect Effects 0.000 description 3
- 230000002439 hemostatic effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010061298 Mucosal haemorrhage Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037549 Purpura Diseases 0.000 description 2
- 241001672981 Purpura Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 206010051373 Wound haemorrhage Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 238000002575 gastroscopy Methods 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 208000031169 hemorrhagic disease Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- HBGOLJKPSFNJSD-UHFFFAOYSA-N Etamsylate Chemical compound CC[NH2+]CC.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 HBGOLJKPSFNJSD-UHFFFAOYSA-N 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010016100 Faeces discoloured Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 101100272680 Paracentrotus lividus BP10 gene Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960003375 aminomethylbenzoic acid Drugs 0.000 description 1
- QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- UUVBYOGFRMMMQL-UHFFFAOYSA-N calcium;phosphoric acid Chemical compound [Ca].OP(O)(O)=O UUVBYOGFRMMMQL-UHFFFAOYSA-N 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 229950006142 carbazochrome salicylate Drugs 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960004817 etamsylate Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 231100000771 fixed dose procedure Toxicity 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229940111260 ginkgo folium Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- -1 hemostasis Substances 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000001118 melena Diseases 0.000 description 1
- 239000008820 moutan cortex Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- CELKBRMLNUNCIP-HTFHIHPASA-M sodium;2-hydroxybenzoate;[(e)-(3-hydroxy-1-methyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O.NC(=O)N\N=C/1C(=O)C=C2N(C)CC(O)C2=C\1 CELKBRMLNUNCIP-HTFHIHPASA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
给药剂量/mg/kg | 实验动物数/只 | 死亡动物数/只 |
340 | 10 | 8 |
304.9 | 10 | 6 |
273.5 | 10 | 3 |
245.3 | 10 | 2 |
220 | 10 | 0 |
CK | 10 | 0 |
组别 | 例数 | 痊愈 | 有效 | 无效 | 有效率 |
治疗组 | 180 | 153 | 27 | 0 | 100% |
对照组 | 72 | 46 | 17 | 9 | 87.5% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102092437A CN102688426B (zh) | 2012-06-25 | 2012-06-25 | 治疗急性上消化道出血的中药组合物、其制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102092437A CN102688426B (zh) | 2012-06-25 | 2012-06-25 | 治疗急性上消化道出血的中药组合物、其制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102688426A true CN102688426A (zh) | 2012-09-26 |
CN102688426B CN102688426B (zh) | 2013-12-18 |
Family
ID=46854270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012102092437A Expired - Fee Related CN102688426B (zh) | 2012-06-25 | 2012-06-25 | 治疗急性上消化道出血的中药组合物、其制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102688426B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104352828A (zh) * | 2014-10-11 | 2015-02-18 | 辛如才 | 一种治疗呕血的中药 |
CN104435950A (zh) * | 2014-11-06 | 2015-03-25 | 赵霞 | 一种治疗上消化道出血症的中药止血散及其制备方法 |
CN104840741A (zh) * | 2015-04-28 | 2015-08-19 | 孙志刚 | 一种治疗消化道出血的中草药 |
CN105381416A (zh) * | 2015-12-25 | 2016-03-09 | 张永红 | 一种治疗上消化道出血的药物及其制备方法 |
CN105497297A (zh) * | 2014-11-05 | 2016-04-20 | 张丽娜 | 一种治疗十二指肠溃疡的中药 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1189366A (zh) * | 1997-01-29 | 1998-08-05 | 唐贵贤 | 胃炎丸 |
CN1403143A (zh) * | 2002-10-17 | 2003-03-19 | 李强华 | 治疗胃肠疾病的组合物中药 |
CN1583131A (zh) * | 2004-06-01 | 2005-02-23 | 北京神农坛医药科技有限公司 | 一种复方丹参冻干粉针剂及其制备方法 |
CN1698803A (zh) * | 2005-06-02 | 2005-11-23 | 北京阜康仁生物制药科技有限公司 | 一种复方三七注射剂制剂及其制备方法 |
CN1876112A (zh) * | 2006-04-19 | 2006-12-13 | 段兴 | 一种治疗胃病的药物及其制备方法 |
CN101874878A (zh) * | 2010-04-23 | 2010-11-03 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗吐血的中药组合物及其制备方法 |
CN102008554A (zh) * | 2010-10-06 | 2011-04-13 | 徐进华 | 一种治疗上消化道出血的中药混合物 |
CN102284008A (zh) * | 2011-07-21 | 2011-12-21 | 刘湘秋 | 一种治疗胃溃疡和十二指肠溃疡的中药颗粒 |
-
2012
- 2012-06-25 CN CN2012102092437A patent/CN102688426B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1189366A (zh) * | 1997-01-29 | 1998-08-05 | 唐贵贤 | 胃炎丸 |
CN1403143A (zh) * | 2002-10-17 | 2003-03-19 | 李强华 | 治疗胃肠疾病的组合物中药 |
CN1583131A (zh) * | 2004-06-01 | 2005-02-23 | 北京神农坛医药科技有限公司 | 一种复方丹参冻干粉针剂及其制备方法 |
CN1698803A (zh) * | 2005-06-02 | 2005-11-23 | 北京阜康仁生物制药科技有限公司 | 一种复方三七注射剂制剂及其制备方法 |
CN1876112A (zh) * | 2006-04-19 | 2006-12-13 | 段兴 | 一种治疗胃病的药物及其制备方法 |
CN101874878A (zh) * | 2010-04-23 | 2010-11-03 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗吐血的中药组合物及其制备方法 |
CN102008554A (zh) * | 2010-10-06 | 2011-04-13 | 徐进华 | 一种治疗上消化道出血的中药混合物 |
CN102284008A (zh) * | 2011-07-21 | 2011-12-21 | 刘湘秋 | 一种治疗胃溃疡和十二指肠溃疡的中药颗粒 |
Non-Patent Citations (2)
Title |
---|
张光明: "中医中药在上消化道出血中的临床运用", 《中外医学研究》, vol. 9, no. 31, 5 November 2011 (2011-11-05), pages 60 - 61 * |
陈桂敏等: "中医药治疗上消化道出血研究进展", 《海南医学院学报》, no. 2, 16 November 2011 (2011-11-16), pages 281 - 283 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104352828A (zh) * | 2014-10-11 | 2015-02-18 | 辛如才 | 一种治疗呕血的中药 |
CN105497297A (zh) * | 2014-11-05 | 2016-04-20 | 张丽娜 | 一种治疗十二指肠溃疡的中药 |
CN104435950A (zh) * | 2014-11-06 | 2015-03-25 | 赵霞 | 一种治疗上消化道出血症的中药止血散及其制备方法 |
CN104840741A (zh) * | 2015-04-28 | 2015-08-19 | 孙志刚 | 一种治疗消化道出血的中草药 |
CN105381416A (zh) * | 2015-12-25 | 2016-03-09 | 张永红 | 一种治疗上消化道出血的药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102688426B (zh) | 2013-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103623388B (zh) | 一种治疗慢性胃炎的中药制剂及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN104383132B (zh) | 一种用于治疗胃溃疡的中药制剂及制备方法 | |
CN102688426B (zh) | 治疗急性上消化道出血的中药组合物、其制备方法及应用 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN104758691A (zh) | 一种治疗前列腺电切术后膀胱过度活动症的中药 | |
CN103735721B (zh) | 一种治疗急性传染性结膜炎的中药 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
CN102166240A (zh) | 治疗肛门直肠疾病的中药组合物及其制备方法 | |
CN101607067B (zh) | 一种治疗胆结石的中药制剂及制备方法 | |
CN101569738A (zh) | 一种治疗乳腺炎、乳腺增生、乳房肿块、关节积液、跌打损伤的膏药及其制备方法与应用 | |
CN105535511A (zh) | 一种和胃止痛颗粒及制备方法 | |
CN103585449A (zh) | 用于治疗偏头痛的中药组合物 | |
CN104306783A (zh) | 一种治疗血友病的中药药物及制备方法 | |
CN103893607A (zh) | 一种治疗胃穿孔的内服药物 | |
CN102716341B (zh) | 治疗急性消化性溃疡出血的中药组合物及其制备方法 | |
CN102940674B (zh) | 治疗前列腺增生的药物组合物 | |
CN102552767A (zh) | 治疗肾结石的中药、制备方法及给药方式 | |
CN105998409A (zh) | 一种治疗痔疮的中药组合物及其制备方法 | |
CN105687878A (zh) | 一种治疗亚急性甲状腺炎的中药及其制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN105709005A (zh) | 一种乳康丸 | |
CN104524149A (zh) | 一种防治急性肾炎的药物组合物及其应用 | |
CN104258302A (zh) | 一种治疗阴虚火旺型慢性特发性血小板减少性紫癜的中药及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: XU MEI Effective date: 20131120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Peng Guihua Inventor after: Wang Yongmei Inventor after: Yu Haitao Inventor after: Di Ping Inventor before: Xu Mei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XU MEI TO: PENG GUIHUA WANG YONGMEI YU HAITAO ZHAI PING Free format text: CORRECT: ADDRESS; FROM: 237200 LU'AN, ANHUI PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131120 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 237200 Anhui city in Lu'an Province, but the streets of Mount Holyoke County Shilin equipment company Jia Miao Zhen Hospital Applicant before: Xu Mei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QIAN XIUYING Free format text: FORMER OWNER: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Effective date: 20141212 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266071 QINGDAO, SHANDONG PROVINCE TO: 213000 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141212 Address after: 213000 Jiangsu city of Changzhou province Kelelu New District No. 1 Srif textile machinery integrated plant 5 Patentee after: Qian Xiuying Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: RUGAO JIANGBEI ADDITIVE CO., LTD. Free format text: FORMER OWNER: QIAN XIUYING Effective date: 20150121 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 213000 CHANGZHOU, JIANGSU PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150121 Address after: 226500 No. 9 Wangjiang Road, Changjiang town (Rugao port), Jiangsu, Rugao Patentee after: Rugao Jiangbei Additive Co., Ltd. Address before: 213000 Jiangsu city of Changzhou province Kelelu New District No. 1 Srif textile machinery integrated plant 5 Patentee before: Qian Xiuying |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131218 Termination date: 20160625 |
|
CF01 | Termination of patent right due to non-payment of annual fee |